Lime is inventing breakthrough lipid-targeting therapeutics using our novel drug discovery platform.
Lab-to-Launch Lounge
Thursday, August 22, 2024
Dr. Shardule Shah is the CEO and co-founder of Lime Therapeutics. In 2022, he was awarded the prestigious Harvard Blavatnik Fellowship for Life Sciences Entrepreneurship and currently holds an Executive Fellow position at Harvard Business School. Prior to co-founding Lime in 2021, Dr. Shah worked in the Bay Area at Lucira Health and Roche Molecular Diagnostics, where he managed cross-functional global clinical operations and regulatory affairs teams for point-of-care diagnostic devices including COVID-19 and influenza testing. Dr. Shah earned his PhD from Emory University in immunology, MBA from Harvard Business School, MS from the University of Pennsylvania in cell biology, and BS from Case Western Reserve University in biochemistry.
One piece of advice to Venturing@Harvard
Never turn down meaningful opportunities to network. They could lead to that right co-founder, investor, and/or customer. And continue grinding away until you hit that inflection point in terms of fundraising. Our first successful pitch (after many unsuccessful ones!) was one in which we received $25,000 from the Harvard iLab's Allston Venture Fund. We used that to create increasing momentum that snowballed into the team and company we are today.
Comments